These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37930837)

  • 1. INTEDE 2.0: the metabolic roadmap of drugs.
    Zhang Y; Liu X; Li F; Yin J; Yang H; Li X; Liu X; Chai X; Niu T; Zeng S; Jia Q; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1355-D1364. PubMed ID: 37930837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTEDE: interactome of drug-metabolizing enzymes.
    Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DrugMAP: molecular atlas and pharma-information of all drugs.
    Li F; Yin J; Lu M; Mou M; Li Z; Zeng Z; Tan Y; Wang S; Chu X; Dai H; Hou T; Zeng S; Chen Y; Zhu F
    Nucleic Acids Res; 2023 Jan; 51(D1):D1288-D1299. PubMed ID: 36243961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DrugBank 4.0: shedding new light on drug metabolism.
    Law V; Knox C; Djoumbou Y; Jewison T; Guo AC; Liu Y; Maciejewski A; Arndt D; Wilson M; Neveu V; Tang A; Gabriel G; Ly C; Adamjee S; Dame ZT; Han B; Zhou Y; Wishart DS
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1091-7. PubMed ID: 24203711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.
    Ossaily S; Zgheib NK
    Drug Metabol Drug Interact; 2014; 29(2):81-90. PubMed ID: 24413215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VARIDT 3.0: the phenotypic and regulatory variability of drug transporter.
    Yin J; Chen Z; You N; Li F; Zhang H; Xue J; Ma H; Zhao Q; Yu L; Zeng S; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1490-D1502. PubMed ID: 37819041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
    Wu JJ; Guo ZZ; Zhu YF; Huang ZJ; Gong X; Li YH; Son WJ; Li XY; Lou YM; Zhu LJ; Lu LL; Liu ZQ; Liu L
    Phytomedicine; 2018 May; 44():187-203. PubMed ID: 29526584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
    Kang SY; Yu KN; Joshi P; Lee MY
    Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of drug metabolism in drug discovery and development.
    Yengi LG; Leung L; Kao J
    Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRESIS: the first comprehensive landscape of drug resistance information.
    Sun X; Zhang Y; Li H; Zhou Y; Shi S; Chen Z; He X; Zhang H; Li F; Yin J; Mou M; Wang Y; Qiu Y; Zhu F
    Nucleic Acids Res; 2023 Jan; 51(D1):D1263-D1275. PubMed ID: 36243960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DrugMAP 2.0: molecular atlas and pharma-information of all drugs.
    Li F; Mou M; Li X; Xu W; Yin J; Zhang Y; Zhu F
    Nucleic Acids Res; 2024 Sep; ():. PubMed ID: 39271119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically relevant genetic variations in drug metabolizing enzymes.
    Pinto N; Dolan ME
    Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
    Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
    Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mapping of drug space from the viewpoint of small molecule metabolism.
    Adams JC; Keiser MJ; Basuino L; Chambers HF; Lee DS; Wiest OG; Babbitt PC
    PLoS Comput Biol; 2009 Aug; 5(8):e1000474. PubMed ID: 19701464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases.
    Xu Y; Yang H; Wu T; Dong Q; Sun Z; Shang D; Li F; Xu Y; Su F; Liu S; Zhang Y; Li X
    Database (Oxford); 2017 Jan; 2017():. PubMed ID: 28605773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPCDR: natural product-based drug combination and its disease-specific molecular regulation.
    Sun X; Zhang Y; Zhou Y; Lian X; Yan L; Pan T; Jin T; Xie H; Liang Z; Qiu W; Wang J; Li Z; Zhu F; Sui X
    Nucleic Acids Res; 2022 Jan; 50(D1):D1324-D1333. PubMed ID: 34664659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
    González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
    Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.